K. Arti

1.4k total citations
78 papers, 671 citations indexed

About

K. Arti is a scholar working on Management of Technology and Innovation, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K. Arti has authored 78 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Management of Technology and Innovation, 36 papers in Economics and Econometrics and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K. Arti's work include Intellectual Property and Patents (48 papers), Pharmaceutical Economics and Policy (22 papers) and Biomedical Ethics and Regulation (18 papers). K. Arti is often cited by papers focused on Intellectual Property and Patents (48 papers), Pharmaceutical Economics and Policy (22 papers) and Biomedical Ethics and Regulation (18 papers). K. Arti collaborates with scholars based in United States, Australia and Belgium. K. Arti's co-authors include W. Nicholson Price, Bhaven N. Sampat, Rebecca S. Eisenberg, Robert Cook‐Deegan, Jerome H. Reichman, Timo Minssen, Stephen M. Maurer, Anthony D. So, Amy Kapczynski and Matthew H. Todd and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

K. Arti

70 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Arti United States 14 324 276 119 101 57 78 671
Jerome H. Reichman United States 19 496 1.5× 362 1.3× 123 1.0× 56 0.6× 104 1.8× 65 986
Jorge L. Contreras United States 13 188 0.6× 140 0.5× 100 0.8× 120 1.2× 64 1.1× 141 612
E. Richard Gold Canada 18 280 0.9× 228 0.8× 204 1.7× 176 1.7× 60 1.1× 87 923
Alexander Schuhmacher Germany 15 109 0.3× 218 0.8× 139 1.2× 144 1.4× 95 1.7× 27 732
Sotaro Shibayama Japan 15 97 0.3× 89 0.3× 55 0.5× 42 0.4× 72 1.3× 48 609
Rochelle Cooper Dreyfuss United States 12 163 0.5× 133 0.5× 37 0.3× 37 0.4× 73 1.3× 81 429
Amy Kapczynski United States 15 188 0.6× 256 0.9× 97 0.8× 8 0.1× 68 1.2× 47 611
Weijun Li China 9 203 0.6× 226 0.8× 119 1.0× 81 0.8× 214 3.8× 17 632
John H. Barton United States 14 178 0.5× 236 0.9× 78 0.7× 68 0.7× 48 0.8× 40 596
Stephen M. Maurer United States 10 83 0.3× 66 0.2× 71 0.6× 128 1.3× 47 0.8× 45 365

Countries citing papers authored by K. Arti

Since Specialization
Citations

This map shows the geographic impact of K. Arti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Arti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Arti more than expected).

Fields of papers citing papers by K. Arti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Arti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Arti. The network helps show where K. Arti may publish in the future.

Co-authorship network of co-authors of K. Arti

This figure shows the co-authorship network connecting the top 25 collaborators of K. Arti. A scholar is included among the top collaborators of K. Arti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Arti. K. Arti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Price, W. Nicholson, et al.. (2025). The puzzle of biologics manufacturing platform patents. Nature Biotechnology. 43(3). 295–299.
2.
Arti, K. & W. Nicholson Price. (2021). An administrative fix for manufacturing process patent thickets. Nature Biotechnology. 39(1). 20–22. 9 indexed citations
3.
Arti, K.. (2019). Machine Learning at the Patent Office: Lessons for Patents and Administrative Law. SSRN Electronic Journal. 7 indexed citations
4.
Arti, K., et al.. (2018). Study on presence of metals in different brands of jam and sauces. Journal of Pharmacognosy and Phytochemistry. 7(6). 922–927. 1 indexed citations
5.
Arti, K., et al.. (2016). Administrative Power in the Era of Patent Stare Decisis. Duke Law Journal. 65(8). 1563–1599. 1 indexed citations
6.
Arti, K., et al.. (2015). When Biopharma Meets Software: Bioinformatics at the Patent Office. eYLS (Yale Law School). 29(1). 205–241. 1 indexed citations
7.
Price, W. Nicholson & K. Arti. (2015). Manufacturing Barriers to Biologics Competition and Innovation. Iowa law review. 101(3). 1023–1063. 5 indexed citations
8.
Arti, K., et al.. (2013). Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery. 11 indexed citations
9.
Arti, K.. (2013). IMPROVING (SOFTWARE) PATENT QUALITY THROUGH THE ADMINISTRATIVE PROCESS.. PubMed Central. 51(2). 503–543. 4 indexed citations
10.
Arti, K. & Robert Cook‐Deegan. (2013). Moving Beyond 'Isolated' Gene Patents. SSRN Electronic Journal. 1 indexed citations
11.
Arti, K.. (2012). Patent Validity Across the Executive Branch: Ex Ante Foundations for Policy Development. Duke Law Journal. 61(6). 1237–1281. 2 indexed citations
12.
Arti, K.. (2009). Growing Pains in the Administrative State: The Patent Office's Troubled Quest for Managerial Control. University of Pennsylvania Law Review. 157(6). 2051. 8 indexed citations
13.
Arti, K., et al.. (2008). Fixing Innovation Policy: A Structural Perspective. 77. 1. 10 indexed citations
14.
So, Anthony D., Bhaven N. Sampat, K. Arti, et al.. (2008). Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience. PLoS Biology. 6(10). e262–e262. 51 indexed citations
15.
Arti, K., et al.. (2007). Synthetic Biology: The Intellectual Property Puzzle. Texas law review. 85(7). 1745. 20 indexed citations
16.
Arti, K.. (2007). The Ends of Intellectual Property: Health as a Case Study. Law and Contemporary Problems. 70(2). 125–130. 1 indexed citations
17.
Arti, K., et al.. (2006). Who's Afraid of the APA? What the Patent System Can Learn from Administrative Law. ˜The œGeorgetown law journal. 95. 270. 4 indexed citations
18.
Arti, K. & Rebecca S. Eisenberg. (2006). Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California's Stem Cell Initiative. Berkeley technology law journal. 21(3). 1187. 3 indexed citations
19.
Arti, K.. (2002). Genome Patents. Academic Medicine. 77(Supplement). 1368–1372. 3 indexed citations
20.
Arti, K.. (2000). Addressing the Patent Gold Rush: The Role of Deference to PTO Patent Denials. Washington University journal of law and policy. 2(1). 199–227. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026